Minimal effective dose of mifepristone for medical abortion.

Q4 Medicine Journal of the Indian Medical Association Pub Date : 2014-02-01
Garima Kapoor, Sudha Salhan, Nivedita Sarda, Deepika Aggarwal
{"title":"Minimal effective dose of mifepristone for medical abortion.","authors":"Garima Kapoor,&nbsp;Sudha Salhan,&nbsp;Nivedita Sarda,&nbsp;Deepika Aggarwal","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of this study is to compare the effectiveness of 100 mg versus 200 mg mifepristone along with misoprostol for medical abortion in gestation upto 56 days. This is a prospective controlled study. Eighty women seeking medical abortion with a gestation up to 56 days were included in the study. The women were randomly allotted into two groups. They received 100 mg/200 mg mifepristone on day 1 followed by 800 mcg misoprostol two days later. Women who had not aborted completely by day 14, received a repeat dose of 400 mcg misoprostol and were evaluated on day 21 for completeness of the procedure. Five women in both the groups had incomplete abortion by day 14 (12.5%), while one woman in the test group had to undergo dilatation and evacuation on day 3 due to excessive bleeding. By repeating a second dose of misoprostol, all of them aborted completely and the complete abortion rates were markedly improved from 85% and 87.5% in the test and the control group, respectively to 97.5% and 100%, respectively. It may be concluded that 100 mg mifepristone is as effective as 200 mg and appears to be the lowest effective dose for medical abortion.</p>","PeriodicalId":17244,"journal":{"name":"Journal of the Indian Medical Association","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2014-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Indian Medical Association","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The aim of this study is to compare the effectiveness of 100 mg versus 200 mg mifepristone along with misoprostol for medical abortion in gestation upto 56 days. This is a prospective controlled study. Eighty women seeking medical abortion with a gestation up to 56 days were included in the study. The women were randomly allotted into two groups. They received 100 mg/200 mg mifepristone on day 1 followed by 800 mcg misoprostol two days later. Women who had not aborted completely by day 14, received a repeat dose of 400 mcg misoprostol and were evaluated on day 21 for completeness of the procedure. Five women in both the groups had incomplete abortion by day 14 (12.5%), while one woman in the test group had to undergo dilatation and evacuation on day 3 due to excessive bleeding. By repeating a second dose of misoprostol, all of them aborted completely and the complete abortion rates were markedly improved from 85% and 87.5% in the test and the control group, respectively to 97.5% and 100%, respectively. It may be concluded that 100 mg mifepristone is as effective as 200 mg and appears to be the lowest effective dose for medical abortion.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
药物流产的最小有效剂量米非司酮。
本研究的目的是比较100毫克与200毫克米非司酮与米索前列醇在妊娠56天内药物流产的有效性。这是一项前瞻性对照研究。80名寻求药物流产且妊娠期长达56天的妇女被纳入研究。这些妇女被随机分为两组。第1天给予米非司酮100 mg/200 mg, 2天后给予米索前列醇800 mcg。未在第14天完全流产的妇女接受400 mcg米索前列醇的重复剂量,并在第21天评估手术的完全性。两组均有5名妇女在第14天发生不完全流产(12.5%),试验组有1名妇女在第3天因出血过多而进行扩张和排出。通过重复第二次米索前列醇治疗,所有患者均完全流产,完全流产率由试验组的85%和对照组的87.5%分别提高到97.5%和100%。可以得出结论,100毫克米非司酮与200毫克一样有效,似乎是药物流产的最低有效剂量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
0
期刊介绍: The Journal of the Indian Medical association, popularly known as JIMA, an indexed (in index medicus) monthly journal, has the largest circulation (over 1.75 lakh Copies per month) of all the indexed and other medical journals of India and abroad. This journal is also available in microfilm through Bell & Howels, USA. The founder leaders of this prestigious journal include Late Sir Nilratan Sircar, Dr Bidhan Chandra Roy, Dr Kumud Sankar Ray and other scholars and doyens of the medical profession. It started in the pre-independence era (1930) with only 122 doctors.
期刊最新文献
Essential thrombocythaemia Medullary carcinoma of the thyroid Animal Bite Family planning. Peripartum cardiomyopathy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1